Dysbiosis and Staphyloccus aureus Colonization Drives Inflammation in Atopic Dermatitis

Immunity

Volumn 42, Issue 4, 2015, Pages 756-766

  Kobayashi, Tetsuro ^a,b   Glatz, Martin ^b   Horiuchi, Keisuke ^a   Kawasaki, Hiroshi ^a   Akiyama, Haruhiko ^c   Kaplan, Daniel H ^d   Kong, Heidi H ^b   Amagai, Masayuki ^a   Nagao, Keisuke ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GIFU UNIVERSITY   (Japan)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYTOKERATIN 14; IMMUNOGLOBULIN E; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; ADAM PROTEIN; ANTIINFECTIVE AGENT; EGFR PROTEIN, MOUSE; EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRASE; SOX9 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORYNEBACTERIUM; CORYNEBACTERIUM BOVIS; CORYNEBACTERIUM MASTITIDIS; DYSBIOSIS; FLOW CYTOMETRY; HAIR FOLLICLE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; LANGERHANS CELL; MOUSE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN FLORA; STAPHYLOCOCCUS AUREUS; TH17 CELL; TH2 CELL; TH22 CELL; ANIMAL; C57BL MOUSE; DEFICIENCY; DERMATITIS, ATOPIC; DRUG EFFECTS; ECZEMA; GENE EXPRESSION REGULATION; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MICROBIOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN; TRANSGENIC MOUSE;

ADAM PROTEINS; ANIMALS; ANTI-BACTERIAL AGENTS; CORYNEBACTERIUM; DERMATITIS, ATOPIC; DYSBIOSIS; ECZEMA; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTEGRASES; LANGERHANS CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN; SOX9 TRANSCRIPTION FACTOR; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84928184443     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.03.014     Document Type: Article

References (53)

1. Bath-Hextall F.J., Birnie A.J., Ravenscroft J.C., Williams H.C. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br. J. Dermatol. 2010, 163:12-26.
2. Blaydon D.C., Biancheri P., Di W.L., Plagnol V., Cabral R.M., Brooke M.A., van Heel D.A., Ruschendorf F., Toynbee M., Walne A., et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N.Engl. J. Med. 2011, 365:1502-1508.
3. Blobel C.P. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 2005, 6:32-43.
4. Chavanas S., Bodemer C., Rochat A., Hamel-Teillac D., Ali M., Irvine A.D., Bonafé J.L., Wilkinson J., Taïeb A., Barrandon Y., et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet. 2000, 25:141-142.
5. Chey W.D., Wong B.C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007, 102:1808-1825. Practice Parameters Committee of the American College of Gastroenterology.
6. Cho I., Yamanishi S., Cox L., Methé B.A., Zavadil J., Li K., Gao Z., Mahana D., Raju K., Teitler I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012, 488:621-626.
7. Eichenfield L.F., Tom W.L., Berger T.G., Krol A., Paller A.S., Schwarzenberger K., Bergman J.N., Chamlin S.L., Cohen D.E., Cooper K.D., et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J.Am. Acad. Dermatol. 2014, 71:116-132.
8. Eilers R.E., Gandhi M., Patel J.D., Mulcahy M.F., Agulnik M., Hensing T., Lacouture M.E. Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J.Natl. Cancer Inst. 2010, 102:47-53.
9. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., Flavell R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
10. Franzke C.W., Cobzaru C., Triantafyllopoulou A., Löffek S., Horiuchi K., Threadgill D.W., Kurz T., van Rooijen N., Bruckner-Tuderman L., Blobel C.P. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J.Exp. Med. 2012, 209:1105-1119.
11. Gittler J.K., Shemer A., Suárez-Fariñas M., Fuentes-Duculan J., Gulewicz K.J., Wang C.Q., Mitsui H., Cardinale I., de Guzman Strong C., Krueger J.G., Guttman-Yassky E. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J.Allergy Clin. Immunol. 2012, 130:1344-1354.
12. Grice E.A., Kong H.H., Conlan S., Deming C.B., Davis J., Young A.C., Bouffard G.G., Blakesley R.W., Murray P.R., Green E.D., et al. Topographical and temporal diversity of the human skin microbiome. Science 2009, 324:1190-1192. NISC Comparative Sequencing Program.
13. Horiuchi K., Kimura T., Miyamoto T., Miyamoto K., Akiyama H., Takaishi H., Morioka H., Nakamura T., Okada Y., Blobel C.P., Toyama Y. Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF. J.Immunol. 2009, 182:2093-2101.
14. Huang J.T., Abrams M., Tlougan B., Rademaker A., Paller A.S. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009, 123:e808-e814.
15. Igyártó B.Z., Haley K., Ortner D., Bobr A., Gerami-Nejad M., Edelson B.T., Zurawski S.M., Malissen B., Zurawski G., Berman J., Kaplan D.H. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011, 35:260-272.
16. Irvine A.D., McLean W.H.I., Leung D.Y.M. Filaggrin mutations associated with skin and allergic diseases. N.Engl. J. Med. 2011, 365:1315-1327.
17. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., Wei D., Goldfarb K.C., Santee C.A., Lynch S.V., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
18. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., Torii H., Asahina A., Onai N., Matsushima K., Tamaki K. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J.Allergy Clin. Immunol. 2001, 107:535-541.
19. Kaplan D.H., Jenison M.C., Saeland S., Shlomchik W.D., Shlomchik M.J. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005, 23:611-620.
20. Kawasaki H., Nagao K., Kubo A., Hata T., Shimizu A., Mizuno H., Yamada T., Amagai M. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J.Allergy Clin. Immunol. 2012, 129:1538-1546.e6.
21. Koga C., Kabashima K., Shiraishi N., Kobayashi M., Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J.Invest. Dermatol. 2008, 128:2625-2630.
22. Kong H.H., Oh J., Deming C., Conlan S., Grice E.A., Beatson M.A., Nomicos E., Polley E.C., Komarow H.D., Murray P.R., et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012, 22:850-859. NISC Comparative Sequence Program.
23. Kubo A., Nagao K., Yokouchi M., Sasaki H., Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J.Exp. Med. 2009, 206:2937-2946.
24. Kubo A., Nagao K., Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J.Clin. Invest. 2012, 122:440-447.
25. Lacouture M.E. Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat. Rev. Cancer 2006, 6:803-812.
26. Leung T.H., Zhang L.F., Wang J., Ning S., Knox S.J., Kim S.K. Topical hypochlorite ameliorates NF-κB-mediated skin diseases in mice. J.Clin. Invest. 2013, 123:5361-5370.
27. Leyden J.J., Marples R.R., Kligman A.M. Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 1974, 90:525-530.
28. Lichtenberger B.M., Gerber P.A., Holcmann M., Buhren B.A., Amberg N., Smolle V., Schrumpf H., Boelke E., Ansari P., Mackenzie C., et al. Epidermal EGFR controls cutaneous host defense and prevents inflammation. Sci. Transl. Med. 2013, 5:199ra111.
29. Lowes M.A., Suárez-Fariñas M., Krueger J.G. Immunology of psoriasis. Annu. Rev. Immunol. 2014, 32:227-255.
30. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E.J. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-781.
31. Mascia F., Lam G., Keith C., Garber C., Steinberg S.M., Kohn E., Yuspa S.H. Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy. Sci. Transl. Med. 2013, 5:199ra110.
32. Merad M., Ginhoux F., Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 2008, 8:935-947.
33. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., et al. Dominant-negativemutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
34. Murthy A., Shao Y.W., Narala S.R., Molyneux S.D., Zúñiga-Pflücker J.C., Khokha R. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity 2012, 36:105-119.
35. Nagao K., Ginhoux F., Leitner W.W., Motegi S., Bennett C.L., Clausen B.E., Merad M., Udey M.C. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. USA 2009, 106:3312-3317.
36. Nagao K., Kobayashi T., Ohyama M., Akiyama H., Horiuchi K., Amagai M. Brief report: requirement of TACE/ADAM17 for hair follicle bulge niche establishment. Stem Cells 2012, 30:1781-1785.
37. Naik S., Bouladoux N., Wilhelm C., Molloy M.J., Salcedo R., Kastenmuller W., Deming C., Quinones M., Koo L., Conlan S., et al. Compartmentalized control of skin immunity by resident commensals. Science 2012, 337:1115-1119.
38. Nograles K.E., Zaba L.C., Shemer A., Fuentes-Duculan J., Cardinale I., Kikuchi T., Ramon M., Bergman R., Krueger J.G., Guttman-Yassky E. IL-22-producing "T22" Tcells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 Tcells. J.Allergy Clin. Immunol. 2009, 123:1244-1252. e1242.
39. Oh J., Conlan S., Polley E.C., Segre J.A., Kong H.H. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med 2012, 4:77.
40. Oh J., Freeman A.F., Park M., Sokolic R., Candotti F., Holland S.M., Segre J.A., Kong H.H., Kong H.H. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res. 2013, 23:2103-2114. NISC Comparative Sequencing Program.
41. Ouchi T., Kubo A., Yokouchi M., Adachi T., Kobayashi T., Kitashima D.Y., Fujii H., Clausen B.E., Koyasu S., Amagai M., Nagao K. Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome. J.Exp. Med. 2011, 208:2607-2613.
42. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., Goudie D.R., Sandilands A., Campbell L.E., Smith F.J., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006, 38:441-446.
43. Paradis M., Lemay S., Scott D.W., Miller W.H., Wellington J., Panich R. Efficacy of Enrofloxacin in the Treatment of Canine Bacterial Pyoderma. Vet. Dermatol. 1990, 1:123-127.
44. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., et al. An essential role for ectodomain shedding in mammalian development. Science 1998, 282:1281-1284.
45. Plant J.D., Gortel K., Kovalik M., Polissar N.L., Neradilek M.B. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis. Vet. Dermatol. 2012, 23. 515-e103.
46. Sääf A., Pivarcsi A., Winge M.C., Wahlgren C.F., Homey B., Nordenskjöld M., Tengvall-Linder M., Bradley M. Characterization of EGFR and ErbB2 expression in atopic dermatitis patients. Arch. Dermatol. Res. 2012, 304:773-780.
47. Schneider L., Tilles S., Lio P., Boguniewicz M., Beck L., LeBovidge J., Novak N., Bernstein D., Blessing-Moore J., Khan D., et al. Atopic dermatitis: a practice parameter update 2012. J.Allergy Clin. Immunol. 2013, 131:295-299. e291-227.
48. Sommer M.O.A., Dantas G. Antibiotics and the resistant microbiome. Curr. Opin. Microbiol. 2011, 14:556-563.
49. Spergel J.M., Paller A.S. Atopic dermatitis and the atopic march. J.Allergy Clin. Immunol. 2003, 112:S118-S127.
50. Suárez-Fariñas M., Dhingra N., Gittler J., Shemer A., Cardinale I., de Guzman Strong C., Krueger J.G., Guttman-Yassky E. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J.Allergy Clin. Immunol. 2013, 132:361-370.
51. Willing B.P., Russell S.L., Finlay B.B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 2011, 9:233-243.
52. Wright G.D. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 2007, 5:175-186.
53. Zhang Z., Xiao C., Gibson A.M., Bass S.A., Khurana Hershey G.K. EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis. J.Immunol. 2014, 192:859-866.